- Details
- Description
Mounjaro 15 mg KwikPen is a prescription, once-weekly injectable medicine containing tirzepatide, a GIP and GLP-1 receptor agonist. It is used to help improve blood-glucose control in adults with type 2 diabetes and, where approved, to support weight management alongside appropriate diet and physical activity. Each dose contains 15 mg of tirzepatide in 0.6 mL, and one multi-dose KwikPen provides 4 weekly doses, containing 60 mg of tirzepatide in 2.4 mL total.
Active substance: Tirzepatide
Strength: 15 mg/0.6 mL per dose
Dosage form: Solution for subcutaneous injection
Pack: 1 multi-dose pre-filled KwikPen containing 4 doses.
Pack contents: Each KwikPen provides 4 doses of 15 mg, with 60 mg tirzepatide in 2.4 mL total. Needles are not included.
Manufacturer: The current product information lists Eli Lilly Italia (Italy), Lilly S.A. (Spain), Lilly France (France), and Millmount Healthcare Limited (Ireland) among the manufacturing sites.
